Last reviewed · How we verify
OGTT
At a glance
| Generic name | OGTT |
|---|---|
| Sponsor | Haugaard, Steen Bendix, M.D., DMSc |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening (NA)
- Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
- Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD
- Wake Forest Alzheimer's Disease Clinical Core
- Screening for Dysglycemia During Postpartum Period in Women With GDM (NA)
- Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes (PHASE2)
- OGTT at Home Using CGM vs at the Clinic (NA)
- Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OGTT CI brief — competitive landscape report
- OGTT updates RSS · CI watch RSS
- Haugaard, Steen Bendix, M.D., DMSc portfolio CI